{"transactions":[{"id":1517608,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-14T16:32:24.000Z","date":"2024-05-10","kind":"grant","planned":false,"acquired":true,"shares":10108,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 10, 2034 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":10108,"derivative":{"exercise_price":5.75,"exercise_date":"2025-05-10","underlying":"Common Stock","underlying_shares":10108},"source":{"system":"sec-edgar","filing":"0001062993-24-010179","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299324010179/form4.xml","form_type":"4"}},{"id":1517607,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-14T16:32:24.000Z","date":"2024-05-10","kind":"grant","planned":false,"acquired":true,"shares":2211,"price":3.96,"value":8755.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the first quarter of 2024. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":2211,"derivative":{"exercise_price":5.75,"exercise_date":"2024-05-10","expiration_date":"2034-05-10","underlying":"Common Stock","underlying_shares":2211},"source":{"system":"sec-edgar","filing":"0001062993-24-010179","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299324010179/form4.xml","form_type":"4"}},{"id":1755247,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-25T16:30:44.000Z","date":"2023-10-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":11291,"price":0.77,"value":8694.07,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This option was canceled by mutual agreement of the reporting person and Vaccinex, Inc. The reporting person received $8,750 as consideration for the cancellation, which represents the reporting person's retainer and meeting fees during the third quarter of 2023."}],"balance_after":0,"derivative":{"exercise_price":1.13,"exercise_date":"2023-09-29","expiration_date":"2033-09-26","underlying":"Common Stock","underlying_shares":11291},"source":{"system":"sec-edgar","filing":"0001062993-23-019700","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299323019700/form4.xml","form_type":"4"}},{"id":1764353,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-05T16:30:13.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":11291,"price":0.77,"value":8694.07,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2023. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":11291,"derivative":{"exercise_price":1.13,"exercise_date":"2023-09-29","expiration_date":"2033-09-26","underlying":"Common Stock","underlying_shares":11291},"source":{"system":"sec-edgar","filing":"0001062993-23-019059","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299323019059/form4.xml","form_type":"4"}},{"id":1764352,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-05T16:30:13.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":2414,"price":3.62,"value":8738.68,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the second quarter of 2023. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":2414,"derivative":{"exercise_price":5.34,"exercise_date":"2023-06-30","expiration_date":"2033-06-27","underlying":"Common Stock","underlying_shares":2414},"source":{"system":"sec-edgar","filing":"0001062993-23-019059","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299323019059/form4.xml","form_type":"4"}},{"id":1893602,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-15T16:32:42.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":143848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":143848,"derivative":{"exercise_price":0.41,"exercise_date":"2024-05-11","underlying":"Common Stock","underlying_shares":143848},"source":{"system":"sec-edgar","filing":"0001062993-23-011115","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299323011115/form4.xml","form_type":"4"}},{"id":1932544,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-03T16:34:57.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":32107,"price":0.27,"value":8668.89,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the first quarter of 2023. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":32107,"derivative":{"exercise_price":0.3995,"exercise_date":"2023-03-31","expiration_date":"2033-03-28","underlying":"Common Stock","underlying_shares":32107},"source":{"system":"sec-edgar","filing":"0001062993-23-008324","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299323008324/form4.xml","form_type":"4"}},{"id":2068092,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-04T16:30:35.000Z","date":"2022-12-31","kind":"grant","acquired":true,"shares":19852,"price":0.44,"value":8734.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the fourth quarter of 2022. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":19852,"derivative":{"exercise_price":0.645,"exercise_date":"2022-12-31","expiration_date":"2032-12-28","underlying":"Common Stock","underlying_shares":19852},"source":{"system":"sec-edgar","filing":"0001062993-23-000300","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299323000300/form4.xml","form_type":"4"}},{"id":2103435,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-28T16:33:48.000Z","date":"2022-11-23","kind":"grant","acquired":true,"shares":188928,"price":0.5293,"value":99999.5904,"ownership":{"direct":false,"nature":"By Gee Eff Services Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Frieberg is the sole owner and President of Gee Eff Services Limited."}],"balance_after":193049,"source":{"system":"sec-edgar","filing":"0001062993-22-022814","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299322022814/form4.xml","form_type":"4"}},{"id":2147517,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-03T16:15:48.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":26260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2022. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":26260,"derivative":{"exercise_price":0.495,"exercise_date":"2022-09-30","expiration_date":"2032-09-27","underlying":"Common Stock","underlying_shares":26260},"source":{"system":"sec-edgar","filing":"0001062993-22-020146","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299322020146/form4.xml","form_type":"4"}},{"id":2217385,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-01T16:30:34.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":12064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the second quarter of 2022. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":12064,"derivative":{"exercise_price":1.08,"exercise_date":"2022-06-30","expiration_date":"2032-06-27","underlying":"Common Stock","underlying_shares":12064},"source":{"system":"sec-edgar","filing":"0001062993-22-015746","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299322015746/form4.xml","form_type":"4"}},{"id":2272152,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-13T16:37:32.000Z","date":"2022-05-12","kind":"grant","acquired":true,"shares":53254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":53254,"derivative":{"exercise_price":1.12,"exercise_date":"2023-05-12","underlying":"Common Stock","underlying_shares":53254},"source":{"system":"sec-edgar","filing":"0001062993-22-012384","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299322012384/form4.xml","form_type":"4"}},{"id":2308475,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-04T16:30:24.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":10032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the first quarter of 2022. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":10032,"derivative":{"exercise_price":1.32,"exercise_date":"2022-03-31","expiration_date":"2032-03-28","underlying":"Common Stock","underlying_shares":10032},"source":{"system":"sec-edgar","filing":"0001062993-22-009441","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299322009441/form4.xml","form_type":"4"}},{"id":2421163,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-31T16:26:28.000Z","date":"2022-01-27","kind":"purchase","acquired":true,"shares":90090,"price":1.11,"value":99999.9,"ownership":{"direct":false,"nature":"By Benbow Estates, Ltd."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Frieberg's spouse is the owner of Benbow Estates, Ltd. and Mr. Frieberg is an officer of Benbow Estates, Ltd. Mr. Frieberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Mr. Frieberg's spouse is the owner of Benbow Estates, Ltd. and Mr. Frieberg is an officer of Benbow Estates, Ltd. Mr. Frieberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Frieberg's spouse is the owner of Benbow Estates, Ltd. and Mr. Frieberg is an officer of Benbow Estates, Ltd. Mr. Frieberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":94510,"source":{"system":"sec-edgar","filing":"0001062993-22-001868","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299322001868/form4.xml","form_type":"4"}},{"id":2454432,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-03T16:17:46.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":12856,"price":0.68,"value":8742.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the fourth quarter of 2021. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":12856,"derivative":{"exercise_price":1.04,"exercise_date":"2021-12-31","expiration_date":"2031-12-29","underlying":"Common Stock","underlying_shares":12856},"source":{"system":"sec-edgar","filing":"0001062993-22-000063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000106299322000063/form4.xml","form_type":"4"}},{"id":2552195,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-04T16:22:40.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":6233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, expires on September 28, 2031."}],"balance_after":6233,"derivative":{"exercise_price":2.16,"exercise_date":"2021-09-30","underlying":"Common Stock","underlying_shares":6233},"source":{"system":"sec-edgar","filing":"0000891839-21-000316","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000089183921000316/edgar.xml","form_type":"4"}},{"id":2645045,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-02T16:07:44.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":4804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, expires on June 28, 2031."}],"balance_after":4804,"derivative":{"exercise_price":2.8,"exercise_date":"2021-06-30","underlying":"Common Stock","underlying_shares":4804},"source":{"system":"sec-edgar","filing":"0000891839-21-000247","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000089183921000247/edgar.xml","form_type":"4"}},{"id":2653630,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Acquire)","published_at":"2021-06-28T16:31:03.000Z","date":"2021-06-25","kind":"exercise","acquired":false,"shares":75000,"ownership":{"direct":false,"nature":"By Gee Eff Services Limited"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Frieberg is the sole owner and President of Gee Eff Services Limited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4121},"source":{"system":"sec-edgar","filing":"0000891839-21-000234","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000089183921000234/edgar.xml","form_type":"4"}},{"id":2653629,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Acquire)","published_at":"2021-06-28T16:31:03.000Z","date":"2021-06-25","kind":"exercise","acquired":false,"shares":44200,"ownership":{"direct":false,"nature":"By Benbow Estates, Ltd."},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Frieberg's spouse is the owner of Benbow Estates, Ltd. and Mr. Frieberg is an officer of Benbow Estates, Ltd. Mr. Frieberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4420},"source":{"system":"sec-edgar","filing":"0000891839-21-000234","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000089183921000234/edgar.xml","form_type":"4"}},{"id":2653628,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Acquire)","published_at":"2021-06-28T16:31:03.000Z","date":"2021-06-25","kind":"exercise","acquired":false,"shares":44200,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4420},"source":{"system":"sec-edgar","filing":"0000891839-21-000234","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000089183921000234/edgar.xml","form_type":"4"}},{"id":2653627,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-28T16:31:03.000Z","date":"2021-06-25","kind":"exercise","acquired":true,"shares":4121,"ownership":{"direct":false,"nature":"By Gee Eff Services Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Partnership interests in VX3 (DE) LP, or VX3 were exchanged into shares of Common Stock on a 1-for-0.05495 basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Frieberg is the sole owner and President of Gee Eff Services Limited."}],"balance_after":4121,"source":{"system":"sec-edgar","filing":"0000891839-21-000234","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000089183921000234/edgar.xml","form_type":"4"}},{"id":2653626,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-28T16:31:03.000Z","date":"2021-06-25","kind":"exercise","acquired":true,"shares":4420,"ownership":{"direct":false,"nature":"By Benbow Estates, Ltd."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Frieberg's spouse is the owner of Benbow Estates, Ltd. and Mr. Frieberg is an officer of Benbow Estates, Ltd. Mr. Frieberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":4420,"source":{"system":"sec-edgar","filing":"0000891839-21-000234","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000089183921000234/edgar.xml","form_type":"4"}},{"id":2653625,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-28T16:31:03.000Z","date":"2021-06-25","kind":"exercise","acquired":true,"shares":4420,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Limited partnership units of Vaccinex Products, LP were exchanged into shares of Common Stock on a 1-for-10 basis."}],"balance_after":57286,"source":{"system":"sec-edgar","filing":"0000891839-21-000234","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000089183921000234/edgar.xml","form_type":"4"}},{"id":2716675,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-12T16:22:19.000Z","date":"2021-05-11","kind":"grant","acquired":true,"shares":28586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":28586,"derivative":{"exercise_price":2.15,"exercise_date":"2022-05-11","underlying":"Common Stock","underlying_shares":28586},"source":{"system":"sec-edgar","filing":"0000891839-21-000135","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000089183921000135/edgar.xml","form_type":"4"}},{"id":2764454,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-01T16:23:29.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":4535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the first quarter of 2021. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":4535,"derivative":{"exercise_price":2.98,"exercise_date":"2021-03-31","expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":4535},"source":{"system":"sec-edgar","filing":"0000891839-21-000089","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000089183921000089/edgar.xml","form_type":"4"}},{"id":2925839,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-04T16:32:00.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":6545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the fourth quarter of 2020. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":6545,"derivative":{"exercise_price":2.07,"exercise_date":"2020-12-31","expiration_date":"2030-12-29","underlying":"Common Stock","underlying_shares":6545},"source":{"system":"sec-edgar","filing":"0000891839-21-000004","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000089183921000004/edgar.xml","form_type":"4"}},{"id":3018672,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T16:31:52.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":7626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2020. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":7626,"derivative":{"exercise_price":1.78,"exercise_date":"2020-09-30","expiration_date":"2030-09-28","underlying":"Common Stock","underlying_shares":7626},"source":{"system":"sec-edgar","filing":"0000891839-20-000296","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000089183920000296/edgar.xml","form_type":"4"}},{"id":3092329,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-02T16:30:52.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":3756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the second quarter of 2020. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":3756,"derivative":{"exercise_price":3.61,"exercise_date":"2020-06-30","expiration_date":"2030-06-28","underlying":"Common Stock","underlying_shares":3756},"source":{"system":"sec-edgar","filing":"0000891839-20-000205","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000089183920000205/edgar.xml","form_type":"4"}},{"id":3145675,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-18T16:23:22.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":15679,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":15679,"derivative":{"exercise_price":3.95,"exercise_date":"2021-05-14","underlying":"Common Stock","underlying_shares":15679},"source":{"system":"sec-edgar","filing":"0000891839-20-000122","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000089183920000122/edgar.xml","form_type":"4"}},{"id":3189359,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-01T16:18:54.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":3336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the first quarter of 2020. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":3336,"derivative":{"exercise_price":4,"exercise_date":"2020-03-31","expiration_date":"2030-03-29","underlying":"Common Stock","underlying_shares":3336},"source":{"system":"sec-edgar","filing":"0000891839-20-000086","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000089183920000086/edgar.xml","form_type":"4"}},{"id":3301471,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-27T16:24:36.000Z","date":"2020-01-23","kind":"purchase","acquired":true,"shares":39292,"price":5.09,"value":199996.28,"ownership":{"direct":true},"balance_after":39292,"source":{"system":"sec-edgar","filing":"0000891839-20-000033","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000089183920000033/edgar.xml","form_type":"4"}},{"id":3310963,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-15T16:20:10.000Z","date":"2019-06-30","kind":"grant","acquired":true,"shares":2385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the second quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":2385,"derivative":{"exercise_price":5.52,"exercise_date":"2019-06-30","expiration_date":"2029-06-29","underlying":"Common Stock","underlying_shares":2385},"source":{"system":"sec-edgar","filing":"0000891839-20-000029","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000089183920000029/edgar.xml","form_type":"4"}},{"id":3318714,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-06T16:33:33.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":2737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the fourth quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable."}],"balance_after":2737,"derivative":{"exercise_price":4.85,"exercise_date":"2019-12-31","expiration_date":"2029-12-28","underlying":"Common Stock","underlying_shares":2737},"source":{"system":"sec-edgar","filing":"0000891839-20-000017","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000089183920000017/edgar.xml","form_type":"4"}},{"id":3318715,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-06T16:30:29.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":1856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all of such options are immediately exerccisable."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The original Form 4 contained an incorrect expiration date for these options. This amendment is being filed to correct the expiration date."}],"balance_after":1856,"derivative":{"exercise_price":7.17,"exercise_date":"2019-09-30","expiration_date":"2029-09-27","underlying":"Common Stock","underlying_shares":1856},"source":{"system":"sec-edgar","filing":"0000891839-20-000015","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000089183920000015/edgar.xml","form_type":"4/A","original_submission_date":"2019-10-04"}},{"id":3397492,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-04T10:56:37.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":1856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all of such options are immediately exercisable."}],"balance_after":1856,"derivative":{"exercise_price":7.17,"exercise_date":"2019-09-30","expiration_date":"2019-09-27","underlying":"Common Stock","underlying_shares":1856},"source":{"system":"sec-edgar","filing":"0001209191-19-052505","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000120919119052505/doc4.xml","form_type":"4"}},{"id":3521355,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-17T16:44:01.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":7718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":7718,"derivative":{"exercise_price":7.78,"exercise_date":"2020-05-15","underlying":"Common Stock","underlying_shares":7718},"source":{"system":"sec-edgar","filing":"0000891839-19-000072","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000089183919000072/edgar.xml","form_type":"4"}},{"id":3569128,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-02T16:28:53.000Z","date":"2019-03-31","kind":"grant","acquired":true,"shares":2501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of the $8,750 cash compensation earned in the first quarter of 2019 for service as a member of the Issuer's board of directors. The number of options was calculated in accordance wih the Black-Scholes valuation model and all of such options are immediately exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of the $8,750 cash compensation earned in the first quarter of 2019 for service as a member of the Issuer's board of directors. The number of options was calculated in accordance wih the Black-Scholes valuation model and all of such options are immediately exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of the $8,750 cash compensation earned in the first quarter of 2019 for service as a member of the Issuer's board of directors. The number of options was calculated in accordance wih the Black-Scholes valuation model and all of such options are immediately exercisable."}],"balance_after":2501,"derivative":{"exercise_price":5.26,"expiration_date":"2029-03-30","underlying":"Common Stock","underlying_shares":2501},"source":{"system":"sec-edgar","filing":"0000891839-19-000057","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000089183919000057/edgar.xml","form_type":"4"}},{"id":3843501,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":91075,"kind":"person","name":"Frieberg Jacob B.","position":1,"cik":"0001748346","reported_name":"Frieberg Jacob B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Acquire)","published_at":"2018-08-15T16:50:19.000Z","date":"2018-08-13","kind":"other","acquired":true,"shares":75000,"ownership":{"direct":false,"nature":"By Gee Eff Services Limited"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Partnership interests in VX3 (DE) LP, or VX3, which are exchangeable into shares of Common Stock on a 1-for-0.05495 basis at the holder's option. On August 13, 2018, Gee Eff Services Limited entered into an exchange agreement with the Issuer and the other partners of VX3 that provides each VX3 partner the right to exchange all, but not less than all, of its partnership interests in VX3 for shares of Common Stock. The option has no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Partnership interests in VX3 (DE) LP, or VX3, which are exchangeable into shares of Common Stock on a 1-for-0.05495 basis at the holder's option. On August 13, 2018, Gee Eff Services Limited entered into an exchange agreement with the Issuer and the other partners of VX3 that provides each VX3 partner the right to exchange all, but not less than all, of its partnership interests in VX3 for shares of Common Stock. The option has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Partnership interests in VX3 (DE) LP, or VX3, which are exchangeable into shares of Common Stock on a 1-for-0.05495 basis at the holder's option. On August 13, 2018, Gee Eff Services Limited entered into an exchange agreement with the Issuer and the other partners of VX3 that provides each VX3 partner the right to exchange all, but not less than all, of its partnership interests in VX3 for shares of Common Stock. The option has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Partnership interests in VX3 (DE) LP, or VX3, which are exchangeable into shares of Common Stock on a 1-for-0.05495 basis at the holder's option. On August 13, 2018, Gee Eff Services Limited entered into an exchange agreement with the Issuer and the other partners of VX3 that provides each VX3 partner the right to exchange all, but not less than all, of its partnership interests in VX3 for shares of Common Stock. The option has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Partnership interests in VX3 (DE) LP, or VX3, which are exchangeable into shares of Common Stock on a 1-for-0.05495 basis at the holder's option. On August 13, 2018, Gee Eff Services Limited entered into an exchange agreement with the Issuer and the other partners of VX3 that provides each VX3 partner the right to exchange all, but not less than all, of its partnership interests in VX3 for shares of Common Stock. The option has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Partnership interests in VX3 (DE) LP, or VX3, which are exchangeable into shares of Common Stock on a 1-for-0.05495 basis at the holder's option. On August 13, 2018, Gee Eff Services Limited entered into an exchange agreement with the Issuer and the other partners of VX3 that provides each VX3 partner the right to exchange all, but not less than all, of its partnership interests in VX3 for shares of Common Stock. The option has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the sole owner and President of Gee Eff Services Limited."}],"balance_after":75000,"derivative":{"underlying":"Common Stock","underlying_shares":4121},"source":{"system":"sec-edgar","filing":"0001123292-18-000929","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1748346/000112329218000929/edgar.xml","form_type":"4"}}]}